{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:52Z","timestamp":1792537792820,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10158-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:04:58Z","timestamp":1779361498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pan-cancer analysis of single-cell profiles with polygenic signals reveals genetic influences on tumor immunity across cancers"],"prefix":"10.1038","volume":"9","author":[{"given":"Chunyu","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-7377","authenticated-orcid":false,"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-6042","authenticated-orcid":false,"given":"Jianzhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-2484","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"10158_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","volume":"13","author":"J Lian","year":"2020","unstructured":"Lian, J., Yue, Y., Yu, W. & Zhang, Y. Immunosenescence: a key player in cancer development. J. Hematol. Oncol. 13, 151 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"10158_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000863","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang, Y. & Abolhassani, H. Updates of cancer hallmarks in patients with inborn errors of immunity. Curr. Opin. Allergy Clin. Immunol. 22, 352\u2013363 (2022).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10158_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1200\/EDBK_200643","volume":"38","author":"E Borcoman","year":"2018","unstructured":"Borcoman, E., Nandikolla, A., Long, G., Goel, S. & Le Tourneau, C. Patterns of Response and Progression to Immunotherapy. Am. Soc. Clin. Oncol. Educ. Book 38, 169\u2013178 (2018).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10158_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.05.010","volume":"41","author":"D Miao","year":"2016","unstructured":"Miao, D. & Allen, E. M. Genomic determinants of cancer immunotherapy. Curr. Opin. Immunol. 41, 32\u201338 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"10158_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"10158_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"key":"10158_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.aau0447","volume":"364","author":"R Mandal","year":"2019","unstructured":"Mandal, R. et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science 364, 485\u2013491 (2019).","journal-title":"Science"},{"key":"10158_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40425-019-0602-4","volume":"7","author":"D Bedognetti","year":"2019","unstructured":"Bedognetti, D. et al. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. J. Immunother. Cancer 7, 131 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"10158_CR9","doi-asserted-by":"publisher","unstructured":"Greten, T. F. et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-023-00816-4 (2023).","DOI":"10.1038\/s41571-023-00816-4"},{"key":"10158_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","volume":"54","author":"RW Sayaman","year":"2021","unstructured":"Sayaman, R. W. et al. Germline genetic contribution to the immune landscape of cancer. Immunity 54, 367\u2013386 368 (2021).","journal-title":"Immunity"},{"key":"10158_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/2326-6066.CIR-21-1017","volume":"10","author":"C Hammer","year":"2022","unstructured":"Hammer, C. & Mellman, I. Coming of age: human genomics and the cancer-immune set point. Cancer Immunol. Res 10, 674\u2013679 (2022).","journal-title":"Cancer Immunol. Res"},{"key":"10158_CR12","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.1073\/pnas.1804506115","volume":"115","author":"YW Lim","year":"2018","unstructured":"Lim, Y. W. et al. Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration. Proc. Natl. Acad. Sci. USA 115, 11701\u201311710 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10158_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38271-5","volume":"14","author":"M Pagadala","year":"2023","unstructured":"Pagadala, M. et al. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response. Nat. Commun. 14, 2744 (2023).","journal-title":"Nat. Commun."},{"key":"10158_CR14","doi-asserted-by":"publisher","unstructured":"Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity. Nat. Genet. https:\/\/doi.org\/10.1038\/s41588-023-01499-4 (2023).","DOI":"10.1038\/s41588-023-01499-4"},{"key":"10158_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"10158_CR16","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1126\/science.abf3041","volume":"376","author":"S Yazar","year":"2022","unstructured":"Yazar, S. et al. Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease. Science 376, 3041 (2022).","journal-title":"Science"},{"key":"10158_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100383","volume":"3","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data. Cell Genom. 3, 100383 (2023).","journal-title":"Cell Genom."},{"key":"10158_CR18","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1126\/science.abl5197","volume":"376","author":"C Dominguez Conde","year":"2022","unstructured":"Dominguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, 5197 (2022).","journal-title":"Science"},{"key":"10158_CR19","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, 6474 (2021).","journal-title":"Science"},{"key":"10158_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2023","unstructured":"Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, 977\u2013985 (2023).","journal-title":"Nucleic Acids Res."},{"key":"10158_CR21","doi-asserted-by":"publisher","first-page":"713230","DOI":"10.3389\/fgene.2021.713230","volume":"12","author":"B Li","year":"2021","unstructured":"Li, B. & Ritchie, M. D. From GWAS to gene: transcriptome-wide association studies and other methods to functionally understand GWAS discoveries. Front Genet 12, 713230 (2021).","journal-title":"Front Genet"},{"key":"10158_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2025.100812","volume":"5","author":"L Bian","year":"2025","unstructured":"Bian, L. et al. Single-cell eQTL mapping reveals cell-type-specific genes associated with the risk of gastric cancer. Cell Genom. 5, 100812 (2025).","journal-title":"Cell Genom."},{"key":"10158_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1507-0","volume":"19","author":"P Geeleher","year":"2018","unstructured":"Geeleher, P. et al. Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity. Genome Biol. 19, 130 (2018).","journal-title":"Genome Biol."},{"key":"10158_CR24","doi-asserted-by":"publisher","first-page":"E7841","DOI":"10.1073\/pnas.1707375114","volume":"114","author":"M Fagny","year":"2017","unstructured":"Fagny, M. et al. Exploring regulation in tissues with eQTL networks. Proc. Natl. Acad. Sci. USA 114, E7841\u2013E7850 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10158_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"10158_CR26","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota, M. et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184, 3006\u20133021 3017 (2021).","journal-title":"Cell"},{"key":"10158_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02933-w","volume":"24","author":"GA Bouland","year":"2023","unstructured":"Bouland, G. A., Mahfouz, A. & Reinders, M. J. T. Consequences and opportunities arising due to sparser single-cell RNA-seq datasets. Genome Biol. 24, 86 (2023).","journal-title":"Genome Biol."},{"key":"10158_CR28","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 37, 1458\u20131465 (2019).","journal-title":"Nat. Biotechnol."},{"key":"10158_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott, D. W. & Gascoyne, R. D. The tumour microenvironment in B cell lymphomas. Nat. Rev. Cancer 14, 517\u2013534 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"10158_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41588-018-0081-4","volume":"50","author":"HK Finucane","year":"2018","unstructured":"Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621\u2013629 (2018).","journal-title":"Nat. Genet."},{"key":"10158_CR31","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","volume":"108","author":"JM Irish","year":"2006","unstructured":"Irish, J. M., Czerwinski, D. K., Nolan, G. P. & Levy, R. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 108, 3135\u20133142 (2006).","journal-title":"Blood"},{"key":"10158_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","volume":"20","author":"AG Kotini","year":"2017","unstructured":"Kotini, A. G. et al. Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia. Cell Stem Cell 20, 315\u2013328.e7 (2017).","journal-title":"Cell Stem Cell"},{"key":"10158_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00790-x","volume":"12","author":"L Kachuri","year":"2020","unstructured":"Kachuri, L. et al. The landscape of host genetic factors involved in immune response to common viral infections. Genome Med. 12, 93 (2020).","journal-title":"Genome Med."},{"key":"10158_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrg2698","volume":"11","author":"LB Barreiro","year":"2010","unstructured":"Barreiro, L. B. & Quintana-Murci, L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 11, 17\u201330 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"10158_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2013252 (2016).","journal-title":"Nat. Genet."},{"key":"10158_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ajhg.2017.09.009","volume":"101","author":"D Calderon","year":"2017","unstructured":"Calderon, D. et al. Inferring relevant cell types for complex traits by using single-cell gene expression. Am. J. Hum. Genet. 101, 686\u2013699 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"10158_CR37","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41588-022-01167-z","volume":"54","author":"MJ Zhang","year":"2022","unstructured":"Zhang, M. J. et al. Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nat. Genet. 54, 1572\u20131580 (2022).","journal-title":"Nat. Genet."},{"key":"10158_CR38","doi-asserted-by":"crossref","unstructured":"Jagadeesh, K. A. et al. Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics. Nat. Genet. 54, 1479\u20131492 (2022).","DOI":"10.1038\/s41588-022-01187-9"},{"key":"10158_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e20 (2019).","journal-title":"Cell"},{"key":"10158_CR40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J. Hepatol. 75, 1397\u20131408 (2021).","journal-title":"J. Hepatol."},{"key":"10158_CR41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aao4572","volume":"359","author":"D Chowell","year":"2018","unstructured":"Chowell, D. et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science 359, 582\u2013587 (2018).","journal-title":"Science"},{"key":"10158_CR42","first-page":"5355","volume":"15","author":"R Zhou","year":"2023","unstructured":"Zhou, R., Zhou, J., Muhuitijiang, B., Zeng, X. & Tan, W. Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer. Aging 15, 5355\u20135380 (2023).","journal-title":"Aging"},{"key":"10158_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41420-023-01356-7","volume":"9","author":"H Zheng","year":"2023","unstructured":"Zheng, H. et al. Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy. Cell Death Discov. 9, 65 (2023).","journal-title":"Cell Death Discov."},{"key":"10158_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/imammb\/dqw021","volume":"35","author":"RS Waters","year":"2018","unstructured":"Waters, R. S., Perry, J. S. A., Han, S., Bielekova, B. & Gedeon, T. The effects of interleukin-2 on immune response regulation. Math. Med Biol. 35, 79\u2013119 (2018).","journal-title":"Math. Med Biol."},{"key":"10158_CR45","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy, K., Colbert, J. D. & Rock, K. L. Cancer immune evasion through loss of MHC Class I antigen presentation. Front. Immunol. 12, 636568 (2021).","journal-title":"Front. Immunol."},{"key":"10158_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25539-x","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis. Nat. Commun. 12, 5291 (2021).","journal-title":"Nat. Commun."},{"key":"10158_CR47","doi-asserted-by":"crossref","unstructured":"Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593 (2018).","DOI":"10.1126\/science.aar3593"},{"key":"10158_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41588-023-01313-1","volume":"55","author":"L Zapata","year":"2023","unstructured":"Zapata, L. et al. Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. Nat. Genet 55, 451\u2013460 (2023).","journal-title":"Nat. Genet"},{"key":"10158_CR49","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1158\/2326-6066.CIR-24-0164","volume":"12","author":"TJ Sears","year":"2024","unstructured":"Sears, T. J. et al. Integrated Germline and Somatic Features Reveal Divergent Immune Pathways Driving Response to Immune Checkpoint Blockade. Cancer Immunol. Res 12, 1780\u20131795 (2024).","journal-title":"Cancer Immunol. Res"},{"key":"10158_CR50","doi-asserted-by":"publisher","unstructured":"Wang, B., Wang, K., Jiang, P. & Ruppin, E. Decoupling the correlation between cytotoxic and exhausted T lymphocyte transcriptomic signatures enhances melanoma immunotherapy response prediction from tumor expression. bioRxiv. https:\/\/doi.org\/10.1101\/2023.01.17.524482 (2023).","DOI":"10.1101\/2023.01.17.524482"},{"key":"10158_CR51","doi-asserted-by":"publisher","first-page":"634119","DOI":"10.3389\/fimmu.2021.634119","volume":"12","author":"AJ Sawyer","year":"2021","unstructured":"Sawyer, A. J., Garand, M., Chaussabel, D. & Feng, C. G. Transcriptomic profiling identifies neutrophil-specific upregulation of Cystatin F as a marker of acute inflammation in humans. Front. Immunol. 12, 634119 (2021).","journal-title":"Front. Immunol."},{"key":"10158_CR52","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fgene.2019.00754","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. The cancer-associated genetic variant Rs3903072 modulates immune cells in the tumor microenvironment. Front. Genet. 10, 754 (2019).","journal-title":"Front. Genet."},{"key":"10158_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.976289","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Advances in the study of HLA class Ib in maternal-fetal immune tolerance. Front Immunol. 13, 976289 (2022).","journal-title":"Front Immunol."},{"key":"10158_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.103980","volume":"158","author":"L Peng","year":"2023","unstructured":"Peng, L. et al. The unique expression pattern of human leukocyte antigen in trophoblasts potentially explains the key mechanism of maternal-fetal tolerance and successful pregnancy. J. Reprod. Immunol. 158, 103980 (2023).","journal-title":"J. Reprod. Immunol."},{"key":"10158_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/cti2.1329","volume":"10","author":"P Girard","year":"2021","unstructured":"Girard, P. et al. Dysfunctional BTN3A together with deregulated immune checkpoints and type I\/II IFN dictate defective interplay between pDCs and gammadelta T cells in melanoma patients, which impacts clinical outcomes. Clin. Transl. Immunol. 10, 1329 (2021).","journal-title":"Clin. Transl. Immunol."},{"key":"10158_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21879-w","volume":"12","author":"J-W Sidhom","year":"2021","unstructured":"Sidhom, J.-W., Larman, H. B., Pardoll, D. M. & Baras, A. S. DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires. Nat. Commun. 12, 1605 (2021).","journal-title":"Nat. Commun."},{"key":"10158_CR57","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1093\/nar\/gkab775","volume":"49","author":"X Shao","year":"2021","unstructured":"Shao, X. et al. scDeepSort: a pre-trained cell-type annotation method for single-cell transcriptomics using deep learning with a weighted graph neural network. Nucleic Acids Res 49, e122 (2021).","journal-title":"Nucleic Acids Res"},{"key":"10158_CR58","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1055\/a-1128-6664","volume":"80","author":"FM Wurfel","year":"2020","unstructured":"Wurfel, F. M. et al. HLA-J, a non-pseudogene as a new prognostic marker for therapy response and survival in breast cancer. Geburtshilfe Frauenheilkd. 80, 1123\u20131133 (2020).","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10158_CR59","doi-asserted-by":"crossref","unstructured":"Zhang, Z. & Zhan, F. Type 2 Cystatins and their roles in the regulation of human immune response and cancer progression. Cancers (Basel) 15, 5363 (2023).","DOI":"10.3390\/cancers15225363"},{"key":"10158_CR60","doi-asserted-by":"crossref","unstructured":"Swatler, J., Ju, Y. J., Anderson, A. C. & Lugli, E. Tumors recycle glucocorticoids to drive Treg-mediated immunosuppression. J. Clin. Invest. 133, e173141 (2023).","DOI":"10.1172\/JCI173141"},{"key":"10158_CR61","doi-asserted-by":"publisher","first-page":"85276","DOI":"10.18632\/oncotarget.19205","volume":"8","author":"D Li","year":"2017","unstructured":"Li, D. et al. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1\/CFL1 pathway to inhibit growth and motility of breast cancer cells. Oncotarget 8, 85276\u201385289 (2017).","journal-title":"Oncotarget"},{"key":"10158_CR62","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"Ebright, R. Y. et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science 367, 1468\u20131473 (2020).","journal-title":"Science"},{"key":"10158_CR63","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla, S. A. et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat. Biotechnol. 33, 1152\u20131158 (2015).","journal-title":"Nat. Biotechnol."},{"key":"10158_CR64","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10549-019-05195-y","volume":"175","author":"AF Groot","year":"2019","unstructured":"Groot, A. F. et al. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res. Treat. 175, 605\u2013615 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"10158_CR65","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723\u2013732 (2018).","journal-title":"Nat. Immunol."},{"key":"10158_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00543-0","volume":"9","author":"L Voorwerk","year":"2023","unstructured":"Voorwerk, L. et al. Immune landscape of breast tumors with low and intermediate estrogen receptor expression. NPJ Breast Cancer 9, 39 (2023).","journal-title":"NPJ Breast Cancer"},{"key":"10158_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00327-8","volume":"8","author":"M Wroblewski","year":"2017","unstructured":"Wroblewski, M. et al. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nat. Commun. 8, 269 (2017).","journal-title":"Nat. Commun."},{"key":"10158_CR68","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","volume":"6","author":"D Sarhan","year":"2018","unstructured":"Sarhan, D. et al. Adaptive NK cells resist regulatory t-cell suppression driven by IL37. Cancer Immunol. Res 6, 766\u2013775 (2018).","journal-title":"Cancer Immunol. Res"},{"key":"10158_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1513421","volume":"15","author":"L Serrano Garc\u00eda","year":"2024","unstructured":"Serrano Garc\u00eda, L. et al. Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review. Front. Immunol. 15, 1513421 (2024).","journal-title":"Front. Immunol."},{"key":"10158_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol. Cancer 23, 251 (2024).","journal-title":"Mol. Cancer"},{"key":"10158_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Sig Transduct. Target Ther. 9, 1\u201336 (2024).","journal-title":"Sig Transduct. Target Ther."},{"key":"10158_CR72","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P. & Gogenur, I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br. J. Cancer 124, 359\u2013367 (2021).","journal-title":"Br. J. Cancer"},{"key":"10158_CR73","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10549-011-1647-3","volume":"130","author":"F Liu","year":"2011","unstructured":"Liu, F. et al. CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res. Treat. 130, 645\u2013655 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"10158_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.abd1329","volume":"372","author":"KE Yost","year":"2021","unstructured":"Yost, K. E., Chang, H. Y. & Satpathy, A. T. Recruiting T cells in cancer immunotherapy. Science 372, 130\u2013131 (2021).","journal-title":"Science"},{"key":"10158_CR75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","volume":"37","author":"E Dheilly","year":"2020","unstructured":"Dheilly, E. et al. Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma. Cancer Cell 37, 674\u2013689 612 (2020).","journal-title":"Cancer Cell"},{"key":"10158_CR76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","volume":"54","author":"RW Sayaman","year":"2021","unstructured":"Sayaman, R. W. et al. Germline genetic contribution to the immune landscape of cancer. Immunity 54, 367\u2013386.e8 (2021).","journal-title":"Immunity"},{"key":"10158_CR77","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2217737","volume":"12","author":"J Fenaux","year":"2023","unstructured":"Fenaux, J. et al. 23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function. Oncoimmunology 12, 2217737 (2023).","journal-title":"Oncoimmunology"},{"key":"10158_CR78","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2767-9764.CRC-24-0568","volume":"5","author":"S Kummar","year":"2025","unstructured":"Kummar, S. et al. First-in-human study of 23ME-00610, an antagonistic antibody for genetically validated CD200R1 immune checkpoint, in participants with advanced solid malignancies. Cancer Res Commun. 5, 94\u2013105 (2025).","journal-title":"Cancer Res Commun."},{"key":"10158_CR79","doi-asserted-by":"publisher","first-page":"241632","DOI":"10.1001\/jamanetworkopen.2024.1632","volume":"7","author":"SJ Rezaei","year":"2024","unstructured":"Rezaei, S. J. et al. Incidence of Nonkeratinocyte skin cancer after breast cancer radiation therapy. JAMA Netw. Open 7, 241632 (2024).","journal-title":"JAMA Netw. Open"},{"key":"10158_CR80","doi-asserted-by":"publisher","first-page":"102989","DOI":"10.1016\/j.critrevonc.2020.102989","volume":"152","author":"A Jeyakumar","year":"2020","unstructured":"Jeyakumar, A., Chua, T. C., Lam, A. K. & Gopalan, V. The melanoma and breast cancer association: an overview of their \u2018Second Primary Cancers\u2019 and the epidemiological, genetic and biological correlations. Crit. Rev. Oncol. Hematol. 152, 102989 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10158_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1263537","volume":"14","author":"P Huang","year":"2023","unstructured":"Huang, P. et al. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer. Front. Immunol. 14, 1263537 (2023).","journal-title":"Front. Immunol."},{"key":"10158_CR82","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","volume":"185","author":"AM Luoma","year":"2022","unstructured":"Luoma, A. M. et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell 185, 2918\u20132935 2929 (2022).","journal-title":"Cell"},{"key":"10158_CR83","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. & Fong, L. Cytotoxic CD4(+) T cells in cancer: Expanding the immune effector toolbox. Immunity 54, 2701\u20132711 (2021).","journal-title":"Immunity"},{"key":"10158_CR84","doi-asserted-by":"publisher","first-page":"10450","DOI":"10.1016\/j.heliyon.2022.e10450","volume":"8","author":"M Dwivedi","year":"2022","unstructured":"Dwivedi, M., Tiwari, S., Kemp, E. H. & Begum, R. Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. Heliyon 8, 10450 (2022).","journal-title":"Heliyon"},{"key":"10158_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li, C., Jiang, P., Wei, S., Xu, X. & Wang, J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol. Cancer 19, 116 (2020).","journal-title":"Mol. Cancer"},{"key":"10158_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.928226","volume":"13","author":"J Yu","year":"2022","unstructured":"Yu, J. et al. Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma. Front. Pharm. 13, 928226 (2022).","journal-title":"Front. Pharm."},{"key":"10158_CR87","doi-asserted-by":"publisher","first-page":"1233376","DOI":"10.3389\/fonc.2023.1233376","volume":"13","author":"J Lee","year":"2023","unstructured":"Lee, J. & Kim, E. H. Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy. Front. Oncol. 13, 1233376 (2023).","journal-title":"Front. Oncol."},{"key":"10158_CR88","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3389\/fonc.2019.01554","volume":"9","author":"BS Guerrouahen","year":"2019","unstructured":"Guerrouahen, B. S., Maccalli, C., Cugno, C., Rutella, S. & Akporiaye, E. T. Reverting immune suppression to enhance cancer immunotherapy. Front. Oncol. 9, 1554 (2019).","journal-title":"Front. Oncol."},{"key":"10158_CR89","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/cea.12780","volume":"46","author":"AO Eifan","year":"2016","unstructured":"Eifan, A. O. & Durham, S. R. Pathogenesis of rhinitis. Clin. Exp. Allergy 46, 1139\u20131151 (2016).","journal-title":"Clin. Exp. Allergy"},{"key":"10158_CR90","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41571-018-0082-3","volume":"15","author":"P Sidaway","year":"2018","unstructured":"Sidaway, P. MHC expression predicts response. Nat. Rev. Clin. Oncol. 15, 591 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10158_CR91","doi-asserted-by":"crossref","unstructured":"Liu, D. H., Mou, F. F., An, M. & Xia, P. Human leukocyte antigen and tumor immunotherapy (Review). Int. J. Oncol. 62, (2023).","DOI":"10.3892\/ijo.2023.5516"},{"key":"10158_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim, N. et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat. Commun. 11, 2285 (2020).","journal-title":"Nat. Commun."},{"key":"10158_CR93","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","volume":"4","author":"N Borcherding","year":"2021","unstructured":"Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).","journal-title":"Commun. Biol."},{"key":"10158_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108367","volume":"26","author":"L Massenet-Regad","year":"2023","unstructured":"Massenet-Regad, L. et al. Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma. iScience 26, 108367 (2023).","journal-title":"iScience"},{"key":"10158_CR95","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809 723 (2021).","journal-title":"Cell"},{"key":"10158_CR96","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","volume":"39","author":"AM Leader","year":"2021","unstructured":"Leader, A. M. et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell 39, 1594\u20131609 1512 (2021).","journal-title":"Cancer Cell"},{"key":"10158_CR97","doi-asserted-by":"crossref","unstructured":"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat. Med. 26, 693\u2013698 (2020).","DOI":"10.1038\/s41591-020-0860-1"},{"key":"10158_CR98","doi-asserted-by":"crossref","unstructured":"Hong, J. Y. et al. Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial. Genome Med. 14, (2022).","DOI":"10.1186\/s13073-021-00995-8"},{"key":"10158_CR99","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","volume":"176","author":"M Sade-Feldman","year":"2019","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 176, 404 (2019).","journal-title":"Cell"},{"key":"10158_CR100","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593 1578 (2021).","journal-title":"Cancer Cell"},{"key":"10158_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21928-4","volume":"12","author":"S Biasi","year":"2021","unstructured":"Biasi, S. et al. Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy. Nat. Commun. 12, 1669 (2021).","journal-title":"Nat. Commun."},{"key":"10158_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med. 15, 14 (2023).","journal-title":"Genome Med."},{"key":"10158_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"10158_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02136-7","volume":"21","author":"PL Germain","year":"2020","unstructured":"Germain, P. L., Sonrel, A. & Robinson, M. D. pipeComp, a general framework for the evaluation of computational pipelines, reveals performant single cell RNA-seq preprocessing tools. Genome Biol. 21, 227 (2020).","journal-title":"Genome Biol."},{"key":"10158_CR105","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900 1885 (2021).","journal-title":"Immunity"},{"key":"10158_CR106","doi-asserted-by":"publisher","unstructured":"Deng, C. Data and code for: Pan-Cancer Analysis of Single-Cell Profiles with Polygenic Signals Reveals Genetic Influences on Tumor Immunity Across Cancers. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19059149 (2026).","DOI":"10.5281\/zenodo.19059149"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10158-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:04:30Z","timestamp":1786532670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10158"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10158-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1089"}}